乙型肝炎■肝霖特写081丨多项研究证实:慢乙肝患者获得HBsAg清除后持久性佳( 三 )


参考文献: [1] Wu Y, Liu Y, Lu J, et al. Durability of Interferon-induced Hepatitis B Surface Antigen Seroclearance[J]. Clin Gastroenterol Hepatol, 2020, 18(2): 514-516 e512.
[2] Li MH, Yi W, Zhang L, et al. Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy[J]. J Viral Hepat, 2019, 26 Suppl 1: 32-41.
[3] Liu Y, Li H, Yan X, et al. Long-term efficacy and safety of peginterferon in the treatment of children with HBeAg-positive chronic hepatitis B[J]. J Viral Hepat, 2019, 26 Suppl 1: 69-76.
[4] Chi H, Wong D, Peng J, et al. Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation[J]. Clin Infect Dis, 2017, 65(4): 680-683.
[5] Lok AS, Zoulim F, Dusheiko G, et al. Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B[J]. Hepatol Commun, 2020, 4(1): 8-20.
[6] Alawad AS, Auh S, Suarez D, et al. Durability of Spontaneous and Treatment-Related Loss of Hepatitis B s Antigen[J]. Clin Gastroenterol Hepatol, 2020, 18(3): 700-709 e703.
[7] Yip TC, Wong GL, Wong VW, et al. Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patients[J]. J Hepatol, 2017.
[8] Wu Y, Wang X, Lin X, et al. Quantitative of serum hepatitis B core antibody is a potential predictor of recurrence after interferon-induced hepatitis B surface antigen clearance[J]. J Microbiol Immunol Infect, 2019.